Michael Davis takes a permanent leadership role at the FDA's Center for Drug Evaluation and Research following senior selections announced by the Department of Health & Human Services.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Michael Davis takes a permanent leadership role at the FDA's Center for Drug Evaluation and Research following senior selections announced by the Department of Health & Human Services.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Center for Drug Evaluation and Research
FDA research center
Nothing else this week.
-
Michael Davis
British writer
Nothing else this week.
Related events
- The FDA appointed Patrizia Cavazzoni to the permanent director role of the Center for Biologics Evaluation and Research (CBER).
- Michael Rogers served in various FDA inspection roles as the Trump administration influenced agency resource allocation.
- The FDA recommended advancement for a new drug application submitted by a company.
- A study author is based in Johns Hopkins School of Medicine, and the research is connected to Baltimore, now involving the FDA for drug approval.
- The FDA and European Medicines Agency discussed sharing the global regulatory leadership mantle.